143 related articles for article (PubMed ID: 36585186)
1. Association of Matrix Metalloproteinase-2 Genotypes With Prostate Cancer Risk.
Li PH; Liao CH; Huang WC; Chang WS; Wu HC; Hsu SW; Chen KY; Wang ZH; Hsia TC; Bau DT; Tsai CW
Anticancer Res; 2023 Jan; 43(1):343-349. PubMed ID: 36585186
[TBL] [Abstract][Full Text] [Related]
2. Association of Matrix Metalloproteinase-7 Genotypes With Prostate Cancer Risk.
Liao CH; Chang WS; Hsu WL; Hu PS; Wu HC; Hsu SW; Wang BR; Yueh TC; Chen CH; Hsia TC; Huang WC; Bau DT; Tsai CW
Anticancer Res; 2023 Jan; 43(1):381-387. PubMed ID: 36585199
[TBL] [Abstract][Full Text] [Related]
3. Contribution of Matrix Metalloproteinase-2 Genotypes to Taiwan Pterygium Risk.
Hu PS; Hsia NY; Wang ZH; Chen HC; Hsia TC; Lin ML; Wang YC; Chang WS; Bau DT; Tsai CW
In Vivo; 2024; 38(2):539-545. PubMed ID: 38418145
[TBL] [Abstract][Full Text] [Related]
4. Association of
Fu CK; Mong MC; Yu CC; Yang MD; Wang ZH; Yang YC; Chen JC; Pei JS; Hsia NY; Tsai CW; Chang WS; Bau DT
Anticancer Res; 2022 Apr; 42(4):1749-1755. PubMed ID: 35346993
[TBL] [Abstract][Full Text] [Related]
5. Association of
Hsu PC; Pei JS; Chen CC; Chang WS; Kuo CC; Cheng SP; Tsai CW; Bau DT; Gong CL
Anticancer Res; 2019 Mar; 39(3):1185-1190. PubMed ID: 30842148
[TBL] [Abstract][Full Text] [Related]
6. Impact of MMP-3 and TIMP-3 gene polymorphisms on prostate cancer susceptibility in North Indian cohort.
Srivastava P; Kapoor R; Mittal RD
Gene; 2013 Nov; 530(2):273-7. PubMed ID: 23872201
[TBL] [Abstract][Full Text] [Related]
7. Role of Matrix Metallopeptidase-2 Genotypes in Taiwanese Patients With Colorectal Cancer.
Yueh TC; Hung YC; Lee HT; Yang MD; Wang ZH; Yang YC; Ke TW; Pei JS; Tsai CW; Bau DT; Chang WS
Anticancer Res; 2022 Nov; 42(11):5335-5342. PubMed ID: 36288896
[TBL] [Abstract][Full Text] [Related]
8. Association of MMP-2, MMP-3, and MMP-9 Polymorphisms with Susceptibility to Recurrent Pregnancy Loss.
Behforouz A; Dastgheib SA; Abbasi H; Karimi-Zarchi M; Javaheri A; Hadadan A; Tabatabaei RS; Meibodi B; Neamatzadeh H
Fetal Pediatr Pathol; 2021 Oct; 40(5):378-386. PubMed ID: 31955640
[TBL] [Abstract][Full Text] [Related]
9. The Contribution of Matrix Metalloproteinase-7 Promoter Genotypes to Hepatocellular Carcinoma Susceptibility.
Yueh TC; Tsao HY; Chien WC; Tsai CW; Pei JS; Wu MH; Chen CP; Chen CC; Wang ZH; Mong MC; Yang YC; Hung YC; Bau DT; Chang WS
Anticancer Res; 2022 Nov; 42(11):5275-5282. PubMed ID: 36288882
[TBL] [Abstract][Full Text] [Related]
10. Contribution of
Tsai CW; Hsu HM; Wang YC; Chang WS; Shih LC; Sun KT; Hung YW; Yang YC; Gong CL; Bau DT
Anticancer Res; 2018 Dec; 38(12):6821-6826. PubMed ID: 30504396
[TBL] [Abstract][Full Text] [Related]
11. Genetic Polymorphism of MMP2 Gene and Susceptibility to Prostate Cancer.
Adabi Z; Mohsen Ziaei SA; Imani M; Samzadeh M; Narouie B; Jamaldini SH; Afshari M; Safavi M; Roshandel MR; Hasanzad M
Arch Med Res; 2015 Oct; 46(7):546-50. PubMed ID: 26319608
[TBL] [Abstract][Full Text] [Related]
12. The Association of Matrix Metalloproteinase-1 Promoter Polymorphisms with Prostate Cancer in Taiwanese Patients.
Liao CH; Wu HC; Hu PS; Hsu SW; Shen TC; Hsia TC; Chang WS; Tsai CW; Bau DT
Anticancer Res; 2018 Jul; 38(7):3907-3911. PubMed ID: 29970511
[TBL] [Abstract][Full Text] [Related]
13. MMP-2 and MMP-9 gene polymorphisms act as biological indicators for ulinastatin efficacy in patients with severe acute pancreatitis.
Ling L; Li Y; Li H; Li W; Zhang HB
Medicine (Baltimore); 2019 Jun; 98(24):e15831. PubMed ID: 31192912
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms in MMP 2, 3, 7, and 9 genes and the susceptibility and clinical outcome of cervical cancer in a Chinese Han population.
Xie B; Zhang Z; Wang H; Chen Z; Wang Y; Liang H; Yang G; Yang X; Zhang H
Tumour Biol; 2016 Apr; 37(4):4883-8. PubMed ID: 26526578
[TBL] [Abstract][Full Text] [Related]
15. Analysis of
Wadowska K; Błasiak P; Rzechonek A; Śliwińska-Mossoń M
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445754
[TBL] [Abstract][Full Text] [Related]
16. Association of Matrix Metalloproteinase-7 Genotypes with the Risk of Bladder Cancer.
Liao CH; Chang WS; Tsai CW; Hu PS; Wu HC; Hsu SW; Chen GL; Yueh TC; Shen TC; Hsia TC; Bau DT
In Vivo; 2018; 32(5):1045-1050. PubMed ID: 30388078
[TBL] [Abstract][Full Text] [Related]
17. Activities and polymorphisms of MMP-2 and MMP-9, smoking, diabetes and risk of prostate cancer.
Kiani A; Kamankesh M; Vaisi-Raygani A; Moradi MR; Tanhapour M; Rahimi Z; Elahi-Rad S; Bahrehmand F; Aliyari M; Aghaz F; Mozafari H; Rezvani N; Haghnazari L; Pourmotabbed T
Mol Biol Rep; 2020 Dec; 47(12):9373-9383. PubMed ID: 33165815
[TBL] [Abstract][Full Text] [Related]
18. Correlations of MMP-2 and MMP-9 gene polymorphisms with the risk of hepatopulmonary syndrome in cirrhotic patients: A case-control study.
Liu JW; Chen DQ
Kaohsiung J Med Sci; 2018 Nov; 34(11):634-642. PubMed ID: 30392570
[TBL] [Abstract][Full Text] [Related]
19. Associations of rs3918242 and rs2285053 MMP-9 and MMP-2 polymorphisms with the risk, severity, and short- and long-term complications of degenerative mitral valve diseases: a 4.8-year prospective cohort study.
Balistreri CR; Allegra A; Crapanzano F; Pisano C; Triolo OF; Argano V; Candore G; Lio D; Ruvolo G
Cardiovasc Pathol; 2016; 25(5):362-70. PubMed ID: 27288746
[TBL] [Abstract][Full Text] [Related]
20. The protective role of the -1306C>T functional polymorphism in matrix metalloproteinase-2 gene is associated with cervical cancer: implication of human papillomavirus infection.
Singh N; Hussain S; Sharma U; Suri V; Nijhawan R; Bharadwaj M; Sobti RC
Tumour Biol; 2016 Apr; 37(4):5295-303. PubMed ID: 26561467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
